CD8A and urinary bladder cancer: Similar to the outcome obtained in the mouse bladder cancer model, the OMV-Ps resulted in elevated levels of CD8+ effector T cells, CD4+ memory T cells, and CD8+ memory T cells in PBMCs and dLNs in the mouse LLC model (Fig. 3f, g).